A 2023 Senate inquiry report described abortion access in Australia as a ‘lottery’. Barbara Baird’s research doesn’t describe chance, but an inadequate system. What needs to change?
Mifepristone’s safety in medication abortions has been well established over more than two decades, but legal wrangling leaves the future of the drug hanging in the balance.
If the ruling to reverse the use of mifepristone stands, it will not only severely restrict abortion access for women throughout the US – it will have far-reaching effects on health care.
A rash of pending lawsuits raises questions about the FDA’s approval of mifepristone two decades ago, whether the drug can be legally mailed and the constitutional right to interstate commerce.
The FDA’s allowance for pharmacies to dispense mifepristone will broaden access to the two-pill mifepristone-misoprostol regimen of medication abortion, which is 95% to 98% effective.
Lauren Ralph, University of California, San Francisco
The fall of Roe v. Wade will result in more people deciding to privately end a pregnancy, a new study finds. But how often people will turn to safe versus unsafe options remains to be seen.